Propiedad y actividad de insiders de Cue Biopharma, Inc. (CUE): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $36.11 |
| Capitalización | $95M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-07-09 | Sarraf Pasha | A-Award | 18,400 | |
| 2026-07-09 | Garzone Pamela | A-Award | 18,900 | |
| 2026-08-13 | Ray Sumita | M-Exempt | 18,196 | |
| 2026-08-13 | Ray Sumita | S-Sale | 2,383 | $70K |
| 2026-08-13 | Ray Sumita | S-Sale | 6,442 | $196K |
| 2026-08-13 | Ray Sumita | S-Sale | 4 | $125 |
| 2026-08-13 | Ray Sumita | M-Exempt | 18,196 | |
| 2026-08-13 | Meluzio Michael Vincent | M-Exempt | 13,647 | |
| 2026-08-13 | Meluzio Michael Vincent | S-Sale | 1,519 | $45K |
| 2026-08-13 | Meluzio Michael Vincent | S-Sale | 4,106 | $125K |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $14.9M | $63.5M | $20.8M | $44.3M | $74.9M | $64.4M | $51.6M | $48.5M | $22.5M | $27.1M |
| Inversiones a Corto | $50033 | $50068 | $18.4M | $15.1M | $10.0M | 0 | $24.7M | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | $754898 | $1.4M | $3.1M | $57000 | $1.7M | $945000 | $7.4M |
| Inventario | 0 | $225500 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $15.1M | $65.1M | $40.6M | $61.0M | $87.5M | $68.5M | $77.2M | $51.5M | $25.1M | $37.0M |
| Inmovilizado Material | $1.0M | $1.7M | $2.8M | $7.2M | $8.9M | $11.9M | $10.7M | $7.1M | $4.8M | $4.3M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | $175000 | 0 | $11667 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $16.3M | $67.0M | $45.4M | $71.6M | $99.5M | $83.4M | $91.3M | $61.5M | $32.2M | $42.2M |
| Cuentas por Pagar | $523811 | $1.3M | $2.0M | $882666 | $2.1M | $2.6M | $2.7M | $3.5M | $2.8M | $3.9M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | $2.0M | $2.0M | $4.0M | $4.3M | 0 |
| Pasivos Corrientes | $1.1M | $5.3M | $6.2M | $11.7M | $16.3M | $12.8M | $11.5M | $17.1M | $13.7M | $13.5M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | $8.0M | $4.2M | 0 | 0 |
| Pasivos Totales | $1.1M | $5.3M | $11.4M | $17.0M | $20.6M | $17.9M | $25.6M | $24.4M | $14.7M | $15.8M |
| Reservas | -$9.6M | -$32.8M | -$71.8M | -$108.5M | -$153.3M | -$197.4M | -$250.5M | -$301.2M | -$341.9M | -$368.5M |
| Patrimonio Neto | $15.2M | $61.6M | $34.0M | $54.6M | $78.9M | $65.5M | $65.7M | $37.1M | $17.5M | $26.4M |
| Deuda Total | 0 | $2.5M | 0 | $5.8M | $7.1M | $12.0M | $19.3M | $14.7M | $8.9M | $4.2M |
| Deuda Neta | -$15.0M | -$61.1M | -$39.2M | -$53.6M | -$77.7M | -$52.3M | -$57.0M | -$33.8M | -$13.6M | -$22.9M |
| Capital Circulante | $14.1M | $59.7M | $34.4M | $49.4M | $71.2M | $55.7M | $65.6M | $34.4M | $11.4M | $23.5M |
Salud financiera
| Deuda / Patrimonio | 0.16 |
| Ratio corriente | 2.74 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -11.88 |
Rentabilidad
| Rentabilidad sobre capital | -100.64% |
| Rentabilidad sobre capital invertido | -86.59% |
| Rentabilidad sobre activos | -63.02% |
| Margen bruto | 100.00% |
| Margen operativo | -96.56% |
| Margen neto | -96.85% |
Empresas relacionadas: BRNS · COEP · EQ · IOBT · IPSC · MDCX · NRXP
Explorar sector: Healthcare · Biotechnology
Más secciones de CUE: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones